SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Giuseppe Banna

Giuseppe Banna

Portsmouth Hospitals University NHS Trust, Portsmouth

Dr. Giuseppe Luigi Banna is a Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust in Portsmouth, United Kingdom, and an Honorary Associate Professor at the University of Portsmouth. His thoracic oncology work focuses on systemic anticancer treatments for lung cancer and the development of predictive immunotherapy models incorporating blood immune-inflammatory indexes, alongside genitourinary malignancies. He has served as Principal Investigator on more than 20 clinical and translational studies, published over 200 peer-reviewed papers, and holds editorial roles including the Journal of the National Cancer Center. He is a frequent speaker at major international thoracic oncology congresses.

Connect

Giuseppe Banna

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates